Jun Yoon

Mr. Yoon has over 20 years of industry operating experience in building and leading venture-backed biotechnology companies. He most recently served as Vice President of Corporate Development at Cellerant Therapeutics, a biotechnology company developing cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. His previous experiences include serving as Sr. Director of Licensing and Business Development at VIA Pharmaceuticals, a public biotechnology company focused on developing therapies for cardiovascular diseases. Mr. Yoon has also held business development roles at MemRx/Sagres Discovery, which focused on oncology therapeutics and was acquired by Chiron/Novartis and was an early employee of Syrrx, a structure-based drug discovery company acquired by Takeda. Mr. Yoon earned his B.A. in molecular cell biology at the University of California, Berkeley.